APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pontine Glioma Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pontine Glioma Drug Industry Growth and Trends Forecast to 2032

19 December 202592 pages

Choose your research edition.

Industry ResearchPontine Glioma Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Pontine Glioma Drug Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Pontine Glioma Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pontine Glioma Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pontine Glioma Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Pontine Glioma Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pontine Glioma Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pontine Glioma Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pontine Glioma Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pontine Glioma Drug include Sanofi, Novogen Limited, Medivation, Inc., Medicenna Therapeutics, Inc., Loxo Oncology, Inc., Burzynski Research Institute, Inc. and Arog Pharmaceuticals, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pontine Glioma Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pontine Glioma Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pontine Glioma Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pontine Glioma Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pontine Glioma Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pontine Glioma Drug Market by Company

Sanofi

Novogen Limited

Medivation, Inc.

Medicenna Therapeutics, Inc.

Loxo Oncology, Inc.

Burzynski Research Institute, Inc.

Arog Pharmaceuticals, Inc.

Pontine Glioma Drug Segment by Type

Afatinib Dimaleate

AZD-1775

AdRTSIL-12

A-10

8H-9

Others

Pontine Glioma Drug Segment by Application

Clinic

Hospital

Others

Pontine Glioma Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pontine Glioma Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pontine Glioma Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pontine Glioma Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pontine Glioma Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pontine Glioma Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Afatinib Dimaleate Table 2. Major Company of AZD-1775 Table 3. Major Company of AdRTSIL-12 Table 4. Major Company of A-10 Table 5. Major Company of 8H-9 Table 6. Major Company of Others Table 7. Global Pontine Glioma Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Pontine Glioma Drug Sales by Type (2021-2026) & (K Units) Table 9. Global Pontine Glioma Drug Sales Market Share in Volume by Type (2021-2026) Table 10. Global Pontine Glioma Drug Sales by Type (2021-2026) & (US$ Million) Table 11. Global Pontine Glioma Drug Sales Market Share in Value by Type (2021-2026) Table 12. Global Pontine Glioma Drug Price by Type (2021-2026) & (US$/Unit) Table 13. Global Pontine Glioma Drug Sales by Type (2027-2032) & (K Units) Table 14. Global Pontine Glioma Drug Sales Market Share in Volume by Type (2027-2032) Table 15. Global Pontine Glioma Drug Sales by Type (2027-2032) & (US$ Million) Table 16. Global Pontine Glioma Drug Sales Market Share in Value by Type (2027-2032) Table 17. Global Pontine Glioma Drug Price by Type (2027-2032) & (US$/Unit) Table 18. North America Pontine Glioma Drug Sales by Type (2021-2026) & (K Units) Table 19. North America Pontine Glioma Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Pontine Glioma Drug Sales by Type (2021-2026) & (K Units) Table 21. Europe Pontine Glioma Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Pontine Glioma Drug Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Pontine Glioma Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Pontine Glioma Drug Sales by Type (2021-2026) & (K Units) Table 25. Latin America Pontine Glioma Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Pontine Glioma Drug Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Pontine Glioma Drug Sales by Type (2021-2026) & (US$ Million) Table 28. Pontine Glioma Drug Industry Trends Table 29. Pontine Glioma Drug Industry Drivers Table 30. Pontine Glioma Drug Industry Opportunities and Challenges Table 31. Pontine Glioma Drug Industry Restraints Table 32. Global Pontine Glioma Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Pontine Glioma Drug Revenue Market Share by Company (2021-2026) Table 34. Global Pontine Glioma Drug Sales by Company (2021-2026) & (K Units) Table 35. Global Pontine Glioma Drug Sales Share by Company (2021-2026) Table 36. Global Pontine Glioma Drug Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Pontine Glioma Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Pontine Glioma Drug Major Company Production Sites and Headquarters Table 39. Global Pontine Glioma Drug Company, Product Type & Application Table 40. Global Pontine Glioma Drug Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Pontine Glioma Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Pontine Glioma Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Pontine Glioma Drug Sales by Region (2021-2026) & (K Units) Table 45. Global Pontine Glioma Drug Sales Market Share in Volume by Region (2021-2026) Table 46. Global Pontine Glioma Drug Sales by Region (2021-2026) & (US$ Million) Table 47. Global Pontine Glioma Drug Sales Market Share in Value by Region (2021-2026) Table 48. Global Pontine Glioma Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Pontine Glioma Drug Sales by Region (2027-2032) & (K Units) Table 50. Global Pontine Glioma Drug Sales Market Share in Volume by Region (2027-2032) Table 51. Global Pontine Glioma Drug Sales by Region (2027-2032) & (US$ Million) Table 52. Global Pontine Glioma Drug Sales Market Share in Value by Region (2027-2032) Table 53. Global Pontine Glioma Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Pontine Glioma Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Pontine Glioma Drug Sales by Application (2021-2026) & (K Units) Table 56. Global Pontine Glioma Drug Sales Market Share in Volume by Application (2021-2026) Table 57. Global Pontine Glioma Drug Sales by Application (2021-2026) & (US$ Million) Table 58. Global Pontine Glioma Drug Sales Market Share in Value by Application (2021-2026) Table 59. Global Pontine Glioma Drug Price by Application (2021-2026) & (US$/Unit) Table 60. Global Pontine Glioma Drug Sales by Application (2027-2032) & (K Units) Table 61. Global Pontine Glioma Drug Sales Market Share in Volume by Application (2027-2032) Table 62. Global Pontine Glioma Drug Sales by Application (2027-2032) & (US$ Million) Table 63. Global Pontine Glioma Drug Sales Market Share in Value by Application (2027-2032) Table 64. Global Pontine Glioma Drug Price by Application (2027-2032) & (US$/Unit) Table 65. North America Pontine Glioma Drug Sales by Application (2021-2026) & (K Units) Table 66. North America Pontine Glioma Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Pontine Glioma Drug Sales by Application (2021-2026) & (K Units) Table 68. Europe Pontine Glioma Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Pontine Glioma Drug Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Pontine Glioma Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Pontine Glioma Drug Sales by Application (2021-2026) & (K Units) Table 72. Latin America Pontine Glioma Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Pontine Glioma Drug Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Pontine Glioma Drug Sales by Application (2021-2026) & (US$ Million) Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Pontine Glioma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Sanofi Pontine Glioma Drug Product Portfolio Table 79. Sanofi Recent Development Table 80. Novogen Limited Company Information Table 81. Novogen Limited Business Overview Table 82. Novogen Limited Pontine Glioma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Novogen Limited Pontine Glioma Drug Product Portfolio Table 84. Novogen Limited Recent Development Table 85. Medivation, Inc. Company Information Table 86. Medivation, Inc. Business Overview Table 87. Medivation, Inc. Pontine Glioma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Medivation, Inc. Pontine Glioma Drug Product Portfolio Table 89. Medivation, Inc. Recent Development Table 90. Medicenna Therapeutics, Inc. Company Information Table 91. Medicenna Therapeutics, Inc. Business Overview Table 92. Medicenna Therapeutics, Inc. Pontine Glioma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Medicenna Therapeutics, Inc. Pontine Glioma Drug Product Portfolio Table 94. Medicenna Therapeutics, Inc. Recent Development Table 95. Loxo Oncology, Inc. Company Information Table 96. Loxo Oncology, Inc. Business Overview Table 97. Loxo Oncology, Inc. Pontine Glioma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Loxo Oncology, Inc. Pontine Glioma Drug Product Portfolio Table 99. Loxo Oncology, Inc. Recent Development Table 100. Burzynski Research Institute, Inc. Company Information Table 101. Burzynski Research Institute, Inc. Business Overview Table 102. Burzynski Research Institute, Inc. Pontine Glioma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Burzynski Research Institute, Inc. Pontine Glioma Drug Product Portfolio Table 104. Burzynski Research Institute, Inc. Recent Development Table 105. Arog Pharmaceuticals, Inc. Company Information Table 106. Arog Pharmaceuticals, Inc. Business Overview Table 107. Arog Pharmaceuticals, Inc. Pontine Glioma Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Arog Pharmaceuticals, Inc. Pontine Glioma Drug Product Portfolio Table 109. Arog Pharmaceuticals, Inc. Recent Development Table 110. North America Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 111. North America Pontine Glioma Drug Sales by Country (2021-2026) & (K Units) Table 112. North America Pontine Glioma Drug Sales Market Share by Country (2021-2026) Table 113. North America Pontine Glioma Drug Sales Forecast by Country (2027-2032) & (K Units) Table 114. North America Pontine Glioma Drug Sales Market Share Forecast by Country (2027-2032) Table 115. North America Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 116. North America Pontine Glioma Drug Market Size by Country (2021-2026) & (US$ Million) Table 117. North America Pontine Glioma Drug Market Share by Country (2021-2026) Table 118. North America Pontine Glioma Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 119. North America Pontine Glioma Drug Market Share Forecast by Country (2027-2032) Table 120. Europe Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 121. Europe Pontine Glioma Drug Sales by Country (2021-2026) & (K Units) Table 122. Europe Pontine Glioma Drug Sales Market Share by Country (2021-2026) Table 123. Europe Pontine Glioma Drug Sales Forecast by Country (2027-2032) & (K Units) Table 124. Europe Pontine Glioma Drug Sales Market Share Forecast by Country (2027-2032) Table 125. Europe Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. Europe Pontine Glioma Drug Market Size by Country (2021-2026) & (US$ Million) Table 127. Europe Pontine Glioma Drug Market Share by Country (2021-2026) Table 128. Europe Pontine Glioma Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. Europe Pontine Glioma Drug Market Share Forecast by Country (2027-2032) Table 130. Asia-Pacific Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 131. Asia-Pacific Pontine Glioma Drug Sales by Country (2021-2026) & (K Units) Table 132. Asia-Pacific Pontine Glioma Drug Sales Market Share by Country (2021-2026) Table 133. Asia-Pacific Pontine Glioma Drug Sales Forecast by Country (2027-2032) & (K Units) Table 134. Asia-Pacific Pontine Glioma Drug Sales Market Share Forecast by Country (2027-2032) Table 135. Asia-Pacific Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Asia-Pacific Pontine Glioma Drug Market Size by Country (2021-2026) & (US$ Million) Table 137. Asia-Pacific Pontine Glioma Drug Market Share by Country (2021-2026) Table 138. Asia-Pacific Pontine Glioma Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Asia-Pacific Pontine Glioma Drug Market Share Forecast by Country (2027-2032) Table 140. Latin America Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 141. Latin America Pontine Glioma Drug Sales by Country (2021-2026) & (K Units) Table 142. Latin America Pontine Glioma Drug Sales Market Share by Country (2021-2026) Table 143. Latin America Pontine Glioma Drug Sales Forecast by Country (2027-2032) & (K Units) Table 144. Latin America Pontine Glioma Drug Sales Market Share Forecast by Country (2027-2032) Table 145. Latin America Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Latin America Pontine Glioma Drug Market Size by Country (2021-2026) & (US$ Million) Table 147. Latin America Pontine Glioma Drug Market Share by Country (2021-2026) Table 148. Latin America Pontine Glioma Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Latin America Pontine Glioma Drug Market Share Forecast by Country (2027-2032) Table 150. Middle East and Africa Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 151. Middle East and Africa Pontine Glioma Drug Sales by Country (2021-2026) & (K Units) Table 152. Middle East and Africa Pontine Glioma Drug Sales Market Share by Country (2021-2026) Table 153. Middle East and Africa Pontine Glioma Drug Sales Forecast by Country (2027-2032) & (K Units) Table 154. Middle East and Africa Pontine Glioma Drug Sales Market Share Forecast by Country (2027-2032) Table 155. Middle East and Africa Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Middle East and Africa Pontine Glioma Drug Market Size by Country (2021-2026) & (US$ Million) Table 157. Middle East and Africa Pontine Glioma Drug Market Share by Country (2021-2026) Table 158. Middle East and Africa Pontine Glioma Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Middle East and Africa Pontine Glioma Drug Market Share Forecast by Country (2027-2032) Table 160. Key Raw Materials Table 161. Raw Materials Key Suppliers Table 162. Pontine Glioma Drug Distributors List Table 163. Pontine Glioma Drug Customers List Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Pontine Glioma Drug Image Figure 2. Global Pontine Glioma Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pontine Glioma Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Pontine Glioma Drug Sales (2021-2032) & (K Units) Figure 5. Afatinib Dimaleate Image Figure 6. Global Afatinib Dimaleate Sales YoY Growth (2021-2032) & (K Units) Figure 7. AZD-1775 Image Figure 8. Global AZD-1775 Sales YoY Growth (2021-2032) & (K Units) Figure 9. AdRTSIL-12 Image Figure 10. Global AdRTSIL-12 Sales YoY Growth (2021-2032) & (K Units) Figure 11. A-10 Image Figure 12. Global A-10 Sales YoY Growth (2021-2032) & (K Units) Figure 13. 8H-9 Image Figure 14. Global 8H-9 Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Pontine Glioma Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Pontine Glioma Drug Market Share by Type 2025 VS 2032 Figure 19. North America Pontine Glioma Drug Sales Market Share in Volume by Type in 2025 Figure 20. North America Pontine Glioma Drug Sales Market Share in Value by Type in 2025 Figure 21. Europe Pontine Glioma Drug Sales Market Share in Volume by Type in 2025 Figure 22. Europe Pontine Glioma Drug Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Pontine Glioma Drug Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Pontine Glioma Drug Sales Market Share in Value by Type in 2025 Figure 25. Latin America Pontine Glioma Drug Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Pontine Glioma Drug Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Pontine Glioma Drug Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Pontine Glioma Drug Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Pontine Glioma Drug Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 33. Hospital Image Figure 34. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Pontine Glioma Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Pontine Glioma Drug Market Share by Application 2025 VS 2032 Figure 39. North America Pontine Glioma Drug Sales Market Share in Volume by Application in 2025 Figure 40. North America Pontine Glioma Drug Sales Market Share in Value by Application in 2025 Figure 41. Europe Pontine Glioma Drug Sales Market Share in Volume by Application in 2025 Figure 42. Europe Pontine Glioma Drug Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Pontine Glioma Drug Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Pontine Glioma Drug Sales Market Share in Value by Application in 2025 Figure 45. Latin America Pontine Glioma Drug Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Pontine Glioma Drug Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Pontine Glioma Drug Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Pontine Glioma Drug Sales Market Share in Value by Application in 2025 Figure 49. North America Pontine Glioma Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Pontine Glioma Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Pontine Glioma Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Pontine Glioma Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Pontine Glioma Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Pontine Glioma Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Pontine Glioma Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Pontine Glioma Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Pontine Glioma Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Pontine Glioma Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Pontine Glioma Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Pontine Glioma Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Pontine Glioma Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Pontine Glioma Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Pontine Glioma Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Pontine Glioma Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Pontine Glioma Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Pontine Glioma Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Pontine Glioma Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Pontine Glioma Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Pontine Glioma Drug Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Pontine Glioma Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Afatinib Dimaleate
  • AZD-1775
  • AdRTSIL-12
  • A-10
  • 8H-9
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Sanofi
  • Novogen Limited
  • Medivation, Inc.
  • Medicenna Therapeutics, Inc.
  • Loxo Oncology, Inc.
  • Burzynski Research Institute, Inc.
  • Arog Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pontine Glioma Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pontine Glioma Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pontine Glioma Drug Market by Type
  6. 1.3.1 Afatinib Dimaleate
  7. 1.3.2 AZD-1775
  8. 1.3.3 AdRTSIL-12
  9. 1.3.4 A-10
  10. 1.3.5 8H-9
  11. 1.3.6 Others
  12. 1.4 Global Pontine Glioma Drug Market Size by Type
  13. 1.4.1 Global Pontine Glioma Drug Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Pontine Glioma Drug Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Pontine Glioma Drug Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Pontine Glioma Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Pontine Glioma Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Pontine Glioma Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Pontine Glioma Drug Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Pontine Glioma Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pontine Glioma Drug Industry Trends
  2. 2.2 Pontine Glioma Drug Industry Drivers
  3. 2.3 Pontine Glioma Drug Industry Opportunities and Challenges
  4. 2.4 Pontine Glioma Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pontine Glioma Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Pontine Glioma Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Pontine Glioma Drug Price (2021-2026)
  4. 3.4 Global Pontine Glioma Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pontine Glioma Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Pontine Glioma Drug Company, Product Type & Application
  7. 3.7 Global Pontine Glioma Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pontine Glioma Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pontine Glioma Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pontine Glioma Drug Tier 1, Tier 2, and Tier 3
4 Pontine Glioma Drug Regional Status and Outlook
  1. 4.1 Global Pontine Glioma Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pontine Glioma Drug Historic Market Size by Region
  3. 4.2.1 Global Pontine Glioma Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pontine Glioma Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pontine Glioma Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pontine Glioma Drug Forecasted Market Size by Region
  7. 4.3.1 Global Pontine Glioma Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pontine Glioma Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pontine Glioma Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pontine Glioma Drug by Application
  1. 5.1 Pontine Glioma Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Pontine Glioma Drug Market Size by Application
  6. 5.2.1 Global Pontine Glioma Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pontine Glioma Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pontine Glioma Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pontine Glioma Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pontine Glioma Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pontine Glioma Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pontine Glioma Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pontine Glioma Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Pontine Glioma Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Pontine Glioma Drug Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novogen Limited
  8. 6.2.1 Novogen Limited Company Information
  9. 6.2.2 Novogen Limited Business Overview
  10. 6.2.3 Novogen Limited Pontine Glioma Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novogen Limited Pontine Glioma Drug Product Portfolio
  12. 6.2.5 Novogen Limited Recent Developments
  13. 6.3 Medivation, Inc.
  14. 6.3.1 Medivation, Inc. Company Information
  15. 6.3.2 Medivation, Inc. Business Overview
  16. 6.3.3 Medivation, Inc. Pontine Glioma Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Medivation, Inc. Pontine Glioma Drug Product Portfolio
  18. 6.3.5 Medivation, Inc. Recent Developments
  19. 6.4 Medicenna Therapeutics, Inc.
  20. 6.4.1 Medicenna Therapeutics, Inc. Company Information
  21. 6.4.2 Medicenna Therapeutics, Inc. Business Overview
  22. 6.4.3 Medicenna Therapeutics, Inc. Pontine Glioma Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Medicenna Therapeutics, Inc. Pontine Glioma Drug Product Portfolio
  24. 6.4.5 Medicenna Therapeutics, Inc. Recent Developments
  25. 6.5 Loxo Oncology, Inc.
  26. 6.5.1 Loxo Oncology, Inc. Company Information
  27. 6.5.2 Loxo Oncology, Inc. Business Overview
  28. 6.5.3 Loxo Oncology, Inc. Pontine Glioma Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Loxo Oncology, Inc. Pontine Glioma Drug Product Portfolio
  30. 6.5.5 Loxo Oncology, Inc. Recent Developments
  31. 6.6 Burzynski Research Institute, Inc.
  32. 6.6.1 Burzynski Research Institute, Inc. Company Information
  33. 6.6.2 Burzynski Research Institute, Inc. Business Overview
  34. 6.6.3 Burzynski Research Institute, Inc. Pontine Glioma Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Burzynski Research Institute, Inc. Pontine Glioma Drug Product Portfolio
  36. 6.6.5 Burzynski Research Institute, Inc. Recent Developments
  37. 6.7 Arog Pharmaceuticals, Inc.
  38. 6.7.1 Arog Pharmaceuticals, Inc. Company Information
  39. 6.7.2 Arog Pharmaceuticals, Inc. Business Overview
  40. 6.7.3 Arog Pharmaceuticals, Inc. Pontine Glioma Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Arog Pharmaceuticals, Inc. Pontine Glioma Drug Product Portfolio
  42. 6.7.5 Arog Pharmaceuticals, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Pontine Glioma Drug Sales by Country
  2. 7.1.1 North America Pontine Glioma Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pontine Glioma Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Pontine Glioma Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pontine Glioma Drug Market Size by Country
  6. 7.2.1 North America Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pontine Glioma Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Pontine Glioma Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pontine Glioma Drug Sales by Country
  2. 8.1.1 Europe Pontine Glioma Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pontine Glioma Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Pontine Glioma Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pontine Glioma Drug Market Size by Country
  6. 8.2.1 Europe Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pontine Glioma Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pontine Glioma Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pontine Glioma Drug Sales by Country
  2. 9.1.1 Asia-Pacific Pontine Glioma Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pontine Glioma Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pontine Glioma Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pontine Glioma Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pontine Glioma Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pontine Glioma Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pontine Glioma Drug Sales by Country
  2. 10.1.1 South America Pontine Glioma Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pontine Glioma Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Pontine Glioma Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pontine Glioma Drug Market Size by Country
  6. 10.2.1 South America Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pontine Glioma Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Pontine Glioma Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pontine Glioma Drug Sales by Country
  2. 11.1.1 Middle East and Africa Pontine Glioma Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pontine Glioma Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pontine Glioma Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pontine Glioma Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Pontine Glioma Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pontine Glioma Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pontine Glioma Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pontine Glioma Drug Value Chain Analysis
  2. 12.1.1 Pontine Glioma Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pontine Glioma Drug Production Mode & Process
  7. 12.2 Pontine Glioma Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pontine Glioma Drug Distributors
  10. 12.2.3 Pontine Glioma Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst